Citric Acid

Citric Acid

SCHEMBL2164477

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Cd+2].[Cd+2].[Cd+2]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.89
ALDH1A1 P00352 1/20 0.33
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL32659668 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL42945 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL22686437 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL29587574 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1291555 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL23012792 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL8845344 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL3597963 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL21555662 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL8042141 0.94 CA4 (0.89) CA4ALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092542-A1 Co/Cd-BASED BIMETALLIC METAL-ORGANIC FRAMEWORK FOR WATER-SPLITTING KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-03-20 US claimed
CN-114657569-B Ferrite compound Z-type heterojunction photo-anode film and preparation method and application thereof 青岛理工大学 2023-10-20 CN claimed
CN-114471457-B Adsorption material and preparation method and application thereof 中国石油化工股份有限公司 2023-07-28 CN claimed
CN-114657569-A Ferrite complex Z-type heterojunction photo-anode film and preparation method and application thereof 青岛理工大学 2022-06-24 CN claimed
CN-114471457-A Adsorbing material and preparation method and application thereof 中国石油化工股份有限公司 2022-05-13 CN claimed
CN-111518396-B High-ductility and high-strength polyamide material and preparation method thereof 江门市融泰新材料科技有限公司 2022-03-11 CN claimed
CN-113755910-A Cyanide-free electroplating cadmium solution with alkyl glycoside as additive component 中国航发北京航空材料研究院 2021-12-07 CN claimed
CN-111518396-A High-ductility and high-strength polyamide material and preparation method thereof 李霞 2020-08-11 CN claimed
US-8173475-B2 Method of producing photoelectric conversion device having a multilayer structure formed on a substrate FUJIFILM CORPORATION (JP) 2012-05-08 US claimed
US-20110186955-A1 METHOD OF PRODUCING PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTRIC CONVERSION DEVICE FUJIFILM CORPORATION (JP) 2011-08-04 US claimed
US-20110189816-A1 METHOD OF PRODUCING PHOTOELECTRIC CONVERSION DEVICE FUJIFILM CORPORATION (JP) 2011-08-04 US claimed
EP-2352172-A2 Method of producing photoelectric conversion device by liquid phase deposition Fujifilm Corporation (JP) 2011-08-03 EP claimed
US-12491493-B1 Amine appended bimetallic metal-organic framework (MOF-74) for carbon dioxide capture and method of preparation thereof KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-12-09 US disclosed
US-12459834-B1 Nanocomposite for wastewater treatment IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-11-04 US disclosed
US-12453960-B1 Nanocomposite material fabrication IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERISTY (SA) 2025-10-28 US disclosed
US-20250282989-A1 SCALE INHIBITORS AND RELATED METHODS LFS CHEMISTRY INCORPORATED (US) 2025-09-11 US disclosed
WO-2002083167-A2 THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY TRACT DISEASE UNIVERSITEIT GENT (BE) 2002-10-24 WO disclosed
EP-0505638-B1 Antimicrobial composition having resistance to heat and weather HAGIWARA RESEARCH CORP (JP) 1997-06-11 EP disclosed
US-5298252-A Silica gel coated with metal aluminum silicate where metal has microbiocidal properties, dispersion in polymer HAGIWARA RESEARCH CORP. (JP) 1994-03-29 US disclosed
EP-0505638-A1 Antimicrobial composition having resistance to heat and weather Hagiwara Research Corporation (JP) 1992-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282989-A1 SCALE INHIBITORS AND RELATED METHODS NUP210, SLC6A19, SLC7A1 CA4 522/4885ALDH1A1 4848/4885CASP1 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.